ROYSTON GROUP PRACTICE
THE SURGERY, 65D MIDLAND ROAD, ROYSTON, BARNSLEYCKD 4
The percentage of patients on the CKD register with hypertension who are treated with an angiotensin coverting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (AEB) (unless a contraindication or side effects are recorded)
Indicator | Year | Numerator | Denominator | Ratio | Centile |
---|---|---|---|---|---|
CKD 4 | 2007 | 288 | 319 | 90.3% | |
CKD 4 | 2008 | 338 | 380 | 88.9% | |
CKD 5 | 2009 | 52 | 56 | 92.9% | |
CKD 5 | 2010 | 23 | 27 | 85.2% | |
CKD 5 | 2011 | 27 | 31 | 87.1% | |
CKD 5 | 2012 | 24 | 31 | 77.4% | |
CKD 5 | 2013 | 26 | 27 | 96.3% | |
CKD003 | 2014 | 29 | 30 | 96.7% | |
CKD003 | 2015 | 28 | 30 | 93.3% | |
NM84 | 2016 | 26 | 36 | 72.2% | |
NM84 | 2017 | 27 | 38 | 71.1% | |
NM84 | 2018 | 25 | 38 | 65.8% | |
NM84 | 2019 | 26 | 36 | 72.2% | |
NM84 | 2020 | 26 | 35 | 74.3% | |
NM84 | 2022 | 22 | 30 | 73.3% | |
NM84 | 2023 | 23 | 29 | 79.3% |